Kraig Biocraft Laboratories, Inc financial data

Symbol
KBLB on OTC
Location
2723 South State Street, Suite 150, Ann Arbor, MI
State of incorporation
Wyoming
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 25.8 % -43.7%
Quick Ratio 0.08 %
Debt-to-equity -150 % +29.1%
Return On Equity 66.7 % -9.25%
Return On Assets -135 % -103%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.04B shares +0.48%
Entity Public Float 42.3M USD -15.4%
Weighted Average Number of Shares Outstanding, Basic 1.04B shares +0.48%
Weighted Average Number of Shares Outstanding, Diluted 1.04B shares +0.48%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 191K USD -15.4%
General and Administrative Expense 2.28M USD +175%
Operating Income (Loss) -3.58M USD -78.6%
Nonoperating Income (Expense) -406K USD +55.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.99M USD -36.9%
Net Income (Loss) Attributable to Parent -3.99M USD -36.9%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.52M USD
Inventory, Net 6.88K USD +4.62%
Assets, Current 1.53M USD -53.1%
Property, Plant and Equipment, Net 53.2K USD -29.2%
Operating Lease, Right-of-Use Asset 71.8K USD +106%
Assets 2.22M USD -42.2%
Accrued Liabilities, Current 191K USD
Liabilities, Current 9.15M USD +9.7%
Operating Lease, Liability, Noncurrent 45.4K USD +165%
Liabilities 9.19M USD +10%
Accumulated Other Comprehensive Income (Loss), Net of Tax 13K USD
Retained Earnings (Accumulated Deficit) -51.8M USD -8.34%
Stockholders' Equity Attributable to Parent -6.97M USD -54.6%
Liabilities and Equity 2.22M USD -42.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -490K USD -23.8%
Net Cash Provided by (Used in) Financing Activities -15K USD 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -505K USD -22.9%
Deferred Tax Assets, Valuation Allowance 5.34M USD +9.32%
Operating Lease, Liability 103K USD +193%
Depreciation 28.3K USD +8.35%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4M USD -179%
Lessee, Operating Lease, Liability, to be Paid 114K USD +196%
Operating Lease, Liability, Current 57.5K USD +219%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.1K USD +51.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 51.7K USD +233%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.2K USD +227%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.32K USD -15.3%
Deferred Tax Assets, Operating Loss Carryforwards 5.34M USD +9.32%
Preferred Stock, Shares Issued 0 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.71K USD +16.5%
Operating Lease, Payments 13.4K USD
Additional Paid in Capital 12.2M USD +11.9%
Preferred Stock, Shares Outstanding 0 shares